| Issue Date |
Title |
Author(s) |
| Oct-2021 |
Clinical remission of rheumatoid arthritis in a multicenter real-world study in Asia-Pacific region |
Sun, Xing;Li, Ru;Cai, Yueming;Al-Herz, Adeeba;Lahiri, Manjari;Choudhury, Minhaj Rahim;Hidayat, Rudy;Suryana, Bagus Putu Putra;Kaneko, Yuko;Fujio, Keishi;Van Hung, Nguyen;Pandya, Sapan;Pang, Leong Khai;Katchamart, Wanruchada;Sigdel, Keshav Raj;Paudyal, Buddhi;Narongroeknawin, Pongthorn;Chevaisrakul, Parawee;Sun, Feng;Lu, Yu;Ho, Carmen;Yeap, Swan Sim;Li, Zhanguo |
| 24-Feb-2021 |
Creating Ferromagnetic Insulating La0.9Ba0.1MnO3 Thin Films by Tuning Lateral Coherence Length |
Yun, Chao;Li, Weiwei;Gao, Xingyao;Dou, Hongyi;Maity, Tuhin;Sun, Xing;Wu, Rui;Peng, Yuxuan;Yang, Jinbo;Wang, Haiyan;MacManus-Driscoll, Judith L. |
| 16-Dec-2021 |
Development and Validation of a Novel Hypoxia-Related Long Noncoding RNA Model With Regard to Prognosis and Immune Features in Breast Cancer |
Gu, Peng;Zhang, Lei;Wang, Ruitao;Ding, Wentao;Wang, Wei;Liu, Yuan;Wang, Wenhao;Li, Zuyin;Yan, Bin;Sun, Xing |
| Jun-2021 |
Diagnostic value of serum connective tissue growth factor in rheumatoid arthritis |
Ren, Jiaqi;Sun, Lin;Sun, Xing;Ma, Zhenzhen;Wang, Xinyu;An, Zhuo;Zhao, Jinxia |
| Feb-2020 |
Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease |
Liu, Yanying;Zhang, Yuxin;Bian, Wenjie;Fu, Jiangnan;Sun, Xing;Chen, Da;Chen, Jiali;Zhao, Xiaozhen;Li, Yingni;Zhang, Wen;Li, Zhanguo |
| May-2022 |
Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/beta-catenin signaling pathway |
Shen, Ling;Gu, Peng;Qiu, Chen;Ding, Wen-Tao;Zhang, Lei;Cao, Wan-Yue;Li, Zu-Yin;Yan, Bin;Sun, Xing |
| 15-Jul-2020 |
Pharmacokinetics and safety of IBI301 versus rituximab in patients with CD20(+) B-cell lymphoma: a multicenter, randomized, double-blind, parallel-controlled study |
Jiang, Bo;Ke, Xiaoyan;Zhang, Qingyuan;Xu, Wei;Su, Hang;Huang, Jie;Zhang, Mingzhi;Wang, Huaqing;Jin, Chuan;Zhu, Jun;Liu, Li;Cai, Zhen;Zhao, Xielan;Zhou, Jianfeng;Zhang, Xiaohong;Liu, Jing;Zhou, Hui;Yu, Jie;Sun, Xing;Qi, Junyuan;Qiu, Lugui |
| Sep-2022 |
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blin |
Lu, Shun;Wu, Lin;Jian, Hong;Chen, Ying;Wang, Qiming;Fang, Jian;Wang, Ziping;Hu, Yanping;Sun, Meili;Han, Liang;Miao, Liyun;Ding, Cuimin;Cui, Jiuwei;Li, Baolan;Pan, Yueyin;Li, Xingya;Ye, Feng;Liu, Anwen;Wang, Ke;Cang, Shundong;Zhou, Hui;Sun, Xing;Ferry, David;Lin, Yong;Wang, Shuyan;Zhang, Wen;Zhang, Chengli |
